AI Image
Trump Administration Delays Threaten Funding for HIV Research
The New York Times • • health
Key Points:
- The future of four major research networks focused on vaccines and treatments for H.I.V., tuberculosis, and emerging infectious diseases is uncertain due to delays from the Trump administration in renewing their funding.
- The National Institutes of Health (NIH) has advised researchers to pause new studies that won’t be completed by the current funding expiration date of November 30, 2027.
- Scientists warn that funding delays could compromise participant safety, disrupt ongoing studies, and cause loss of momentum in critical medical research.
- Dr. Emily Erbelding highlighted the significant negative impact of funding interruptions on research progress and expressed concern that decision-makers may not fully grasp these consequences.
- The Department of Health and Human Services has not provided clarity on when or if the NIH will initiate the funding renewal process for these networks.
